3B BlackBio Dx Limited

Web: kilpest.com NSE: 3BBLACKBIO BSE: 532067 SECTOR: Healthcare - Healthcare Services | Add Note | View Notes

1426 60(-4%)

Near 52W High of 1547

Volume

11k as on 23, Jun

Open

1,983

High

2,045

Low

1,983

1,486

VWAP

1,191

52 Week High

1,547

52 Week Low

1,085

Viand Research Rating

Quality Score

46/100

Growth Score

68/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,224

No. of Shares

0.86

P/E

32.81

P/B

6.21

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

18.94

ROCE

Profit Growth

Listing Date

Promoter Holding

40.95%

FII Holding

2.5%

DII Holding

2.15%

Price Chart

Price Performance

1 Week6%

1 Month2%

3 Months9%

6 Months9%

1 Year9%

YTD9%

Moving Average

5 Day SMA1,197

10 Day SMA1,228

20 Day SMA1,195

30 Day SMA1,221

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,296	1,220	1,261	1,300
Resistance 2	1,261	1,215	1,236	1,262
Resistance 1	1,232	1,209	1,221	1,235
Pivot Point	1,196	1,203	1,196	1,198
Support 1	1,167	1,197	1,171	1,170
Support 2	1,131	1,191	1,156	1,133
Support 3	1,102	1,185	1,131	1,106

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 40.95%	(-0.31) 40.94%	(0.01) 41.27%	(0.01) 41.28%	(0.01) 41.28%	(0.01) 41.28%	(0.01) 41.28%	(0.01) 41.28%	(0.01) 41.28%	(2.91) 41.29%	(0.01) 38.43%	(0.01) 38.43%	(0.01) 38.43%	(0.01) 38.43%	(0.01) 38.43%	(0.01) 38.43%	(0.01) 38.43%	(0.01) 38.43%	(0.01) 38.43%
FIIs	(-0.11) 2.50%	(0.01) 2.57%	(-0.11) 2.57%	(-0.11) 2.64%	(0.21) 2.70%	(-0.21) 2.49%	(-0.61) 2.68%	(0.01) 3.27%	(0.31) 3.28%	(-0.41) 2.97%	(0.21) 3.38%	(0.11) 3.16%	(0.51) 3.06%	(0.41) 2.54%	(0.51) 2.11%	(0.01) 1.64%	(0.01) 1.64%	(0.41) 1.64%	(0.01) 1.23%
DIIs	(0.21) 2.15%	(0.11) 1.98%	(0.11) 1.87%	(0.11) 1.82%	(0.21) 1.76%	(-0.11) 1.60%	(-0.21) 1.74%	(0.01) 1.96%	(0.11) 1.96%	(0.71) 1.89%	(0.41) 1.18%	(0.81) 0.82%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.11) 0.00%	(0.01) 0.08%	(0.01) 0.08%	(0.01) 0.08%
Public	54.40%	54.50%	54.27%	54.26%	54.28%	54.64%	54.29%	53.48%	53.48%	53.85%	56.99%	57.60%	58.50%	59.02%	59.47%	59.94%	59.85%	59.85%	60.26%
No. of Shareholders	11,049	10,616	10,507	10,709	10,619	10,345	10,166	9,586	9,399	9,753	10,088	10,513	12,416	13,136	13,798	15,415	16,316	16,468	16,756

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	33.49	35.43	50.35	33.9	22.23	22.5	25.39	29.15	19.43	23	17.67	19.18	14.28	18.11	15	17	12	18.4	14	15
Sales Growth % (YoY)	51%	57%	98%	16%	14%	-2%	44%	52%	36%	27%	20%	11%	22%	-2%	3%	13.7%	-64.2%	-2.5%	-66.4%	-86%
Sales Growth % (QoQ)	-5.5%	-29.6%	48.5%	52.5%	-1.2%	-11.4%	-12.9%	50%	-15.5%	30.2%	-7.9%	34.3%	-21.1%	20.7%	-11.8%	41.7%	-34.8%	31.4%	-6.7%	-
Expenses	24.97	26.94	28.63	19.17	10.4	14.58	10.32	12.98	8.48	13.12	8.8	11.39	7.84	10.65	7	8	7	12.48	7	9
Operating Profit	8.52	8.49	21.72	14.73	11.83	7.92	15.07	16.17	10.95	9.88	8.87	7.79	6.44	7.46	7	9	5	5.92	7	6
OPM %	25.44	23.96	43.14	43.45	53.22	35.2	59.35	55.47	56.36	42.96	50.2	40.62	45.1	41.19	50	53	44	32.17	49	39
Other Income	6.14	10.15	5.59	5.51	4.32	4.94	3.01	3.44	3.69	4.19	2.63	2.75	2.96	1.15	3	2	1	1.87	2	2
Interest	0.1	0.1	0.09	0.04	0.01	0.04	0.02	0.03	0.01	0.04	0.03	0.04	0.02	0.04	0	0	0	-0.02	0	0
Depreciation	1.34	3.89	0.38	0.58	0.28	0.28	0.27	0.27	0.27	0.3	0.32	0.24	0.19	0.21	0	0	0	0.17	0	0
Profit before tax	13.22	14.65	26.84	19.62	15.86	12.54	17.79	19.31	14.36	13.73	11.15	10.26	9.19	8.36	10	11	6	7.64	8	8
Tax %	32.07	33.11	16.39	23.34	20.3	35.89	24.17	22.99	21.31	35.98	23.68	26.02	21.55	37.8	22	23	24	36.91	21	24
Net Profit	8.98	9.81	22.44	15.04	12.65	8.04	13.49	14.87	11.3	8.79	8.51	7.58	7.21	5.19	8	8	5	4.82	7	6
Net Profit Growth % (QoQ)	-8.5%	-56.3%	49.2%	18.9%	57.3%	-40.4%	-9.3%	31.6%	28.6%	3.3%	12.3%	5.1%	38.9%	-35.1%	-	60%	3.7%	-31.1%	16.7%	-
Net Profit Growth % (YoY)	-29%	22%	66.3%	1.1%	11.9%	-8.5%	58.5%	96.2%	56.7%	69.4%	6.4%	-5.2%	44.2%	7.7%	14.3%	33.3%	-	-	-	-
TTM Net Profit	56.27	59.94	58.17	49.22	49.05	47.7	48.45	43.47	36.18	32.09	28.49	27.98	28.4	26.19	25.82	24.82	22.82	17.82	13	0
EPS in Rs	11.1	11.14	25.32	17.14	14.67	9.79	15.61	17.07	12.97	10.33	10.16	10.46	9.71	7.72	8.96	11.2	5.39	5.53	7.66	6.85

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	142	96	74	62	81	227	29	23	23	16	17	19	22	20
Sales Growth %	47.1%	30.2%	19.9%	-23.3%	-64.4%	685.4%	24%	0.3%	43.6%	-6.8%	-8.4%	-13.8%	8.4%	-4.9%
Expenses	85	46	41	33	44	77	20	16	18	14	16	18	21	19
Operating Profit	57	50	33	29	37	150	9	7	5	3	2	1	1	1
OPM %	40	52	44	47	46	66	32	31	23	16	9	7	6	6
Other Income	26	15	13	7	7	3	2	1	0	0	0	0	0	0
Interest	0	0	0	0	0	0	0	0	1	1	1	1	1	1
Depreciation	5	1	1	1	1	1	1	1	0	0	0	0	0	0
Profit before tax	77	64	44	35	43	152	10	7	5	1	0	0	0	1
Tax %	22	25	28	27	26	25	23	25	24	19	23	23	14	34
Net Profit	60	48	32	26	32	114	8	5	3	1	0	0	0	0
Net Profit Growth %	25%	50%	23.1%	-18.8%	-71.9%	1325%	60%	66.7%	200%	-	-	-	-	-
EPS in Rs	68.27	55.57	37.4	34.55	42.89	151.66	10.24	8.18	5.35	1.76	0.51	0.36	0.59	0.62
Dividend Payout %	7	7	8	8	24	6	7	6	9	17	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2013
Cash from Operating Activity	52	43	27	20	37	98	7	4	2	1	1	-1
Cash from Investing Activity	-24	-33	-20	15	-28	-70	-1	-1	-1	0	0	0
Cash from Financing Activity	-1	-3	-4	-5	-15	-2	1	-1	0	0	-1	0
Net Cash Flow	28	7	3	30	-6	26	7	2	1	0	0	-1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	9	9	9	9	9	9	7	7	7	6	6	6	6	6	6	6
Reserves	316	290	260	238	214	185	146	125	25	16	12	5	4	4	4	3
Borrowings	3	0	0	1	1	2	3	2	4	6	6	9	8	8	7	6
Other Liabilities	51	42	27	22	24	19	37	59	9	8	6	6	6	7	7	7
Total Liabilities	378	341	296	269	248	214	192	194	45	36	30	26	24	25	24	23
Fixed Assets	28	17	7	7	7	8	7	5	4	4	4	3	3	4	4	4
CWIP	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	158	160	156	133	117	92	93	59	1	0	0	0	0	0	0	0
Other Assets	193	163	132	129	123	114	93	130	40	32	26	22	21	21	20	19
Total Assets	378	341	296	269	248	214	192	194	45	36	30	26	24	25	24	23

Delivery

Delivery Data: 3BBLACKBIO

#	Date	1100 45% 1589	Value (Cr)	Q/T 11	Del 58	Del 2
1	4-Sep	1460	3	8	45	1
2	3-Sep	1486	3	10	59	2
3	2-Sep	1479	8	10	56	4
4	1-Sep	1524	6	10	41	3
5	31-Aug	1448	5	12	63	3
6	28-Aug	1441	6	15	49	3
7	27-Aug	1350	2	8	65	1
8	26-Aug	1306	2	10	59	1
9	25-Aug	1262	1	8	56	1
10	24-Aug	1262	4	11	60	3
11	21-Aug	1202	2	10	64	1
12	20-Aug	1151	2	11	58	1
13	19-Aug	1144	2	13	55	1
14	18-Aug	1148	1	15	73	1
15	17-Aug	1148	2	16	80	2
16	14-Aug	1175	3	11	65	2
17	13-Aug	1226	1	10	56	1
18	12-Aug	1251	1	7	56	0
19	11-Aug	1208	1	8	50	0
20	10-Aug	1245	0	6	54	0
21	7-Aug	1208	0	7	52	0
22	6-Aug	1206	1	11	74	0
23	5-Aug	1204	1	7	63	1
24	4-Aug	1238	1	6	65	1
25	3-Aug	1248	1	8	53	0
26	31-Jul	1247	0	8	63	0
27	30-Jul	1250	0	8	60	0
28	29-Jul	1271	1	6	58	0
29	28-Jul	1299	1	7	57	1
30	27-Jul	1292	1	9	54	1
31	24-Jul	1278	1	7	60	0
32	23-Jul	1276	1	9	72	1
33	22-Jul	1290	1	11	53	1
34	21-Jul	1272	1	8	60	1
35	20-Jul	1267	2	9	45	1
36	17-Jul	1250	2	15	66	2
37	16-Jul	1268	3	11	51	1
38	15-Jul	1270	6	10	55	3
39	14-Jul	1183	3	8	49	1
40	13-Jul	1215	2	8	62	1
41	10-Jul	1149	1	10	54	1
42	9-Jul	1168	1	7	58	0
43	8-Jul	1166	2	7	49	1
44	7-Jul	1168	1	8	58	1
45	6-Jul	1208	2	6	37	1
46	3-Jul	1174	1	6	52	0
47	2-Jul	1206	0	6	59	0
48	1-Jul	1201	1	8	56	0
49	30-Jun	1169	0	8	61	0
50	29-Jun	1174	0	6	52	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	1,224c	53c	4.12
03-Sep	1,276c	1c	0.09
01-Sep	1,275c	13c	1.04
31-Aug	1,262c	149c	13.36
26-Aug	1,113c	41c	3.85
25-Aug	1,072c	14c	1.33
24-Aug	1,086c	96c	9.74
21-Aug	990c	6c	0.58
19-Aug	984c	3c	0.27
18-Aug	987c	3c	0.34
17-Aug	984c	25c	2.46
14-Aug	1,009c	54c	5.09
13-Aug	1,063c	15c	1.35
12-Aug	1,077c	12c	1.14
11-Aug	1,065c	0	0
10-Aug	1,065c	16c	1.55
06-Aug	1,049c	5c	0.49
05-Aug	1,044c	10c	0.94
04-Aug	1,054c	19c	1.76
31-Jul	1,072c	4c	0.38
30-Jul	1,077c	25c	2.30
29-Jul	1,102c	2c	0.20
28-Jul	1,100c	14c	1.26
27-Jul	1,114c	0	0

Stock Checklist

Price is above from 52 week high low average: 74%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: YES

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.05%	-	0

3B BlackBio Dx Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements